...
首页> 外文期刊>Journal of otolaryngology - head & neck surgery = >Opioid prescribing practices following elective surgery in Otolaryngology-Head & Neck Surgery
【24h】

Opioid prescribing practices following elective surgery in Otolaryngology-Head & Neck Surgery

机译:耳鼻咽喉头颈外科择期手术后的阿片类药物处方操作

获取原文
           

摘要

Prescription opioid abuse has become a major issue across the world and especially in North America. Canada has the second highest number of opioid prescriptions per capita in the world, second only to the United States, with numbers continuing to rise in recent years. Surgeons play a critical role in this discussion as they are responsible for the management of post-operative pain in their patients. The objective of this study is to evaluate the opioid prescribing practices of Otolaryngologists-Head and Neck Surgeons in Canada and determine factors that may influence these practices. The online survey was distributed to members of the Canadian Society of Otolaryngology-Head and Neck Surgery. Questions surveyed the respondents’ demographics and opioid prescribing practices for common pediatric and adult elective surgeries. The survey was sent to 670 surgeons and trainees and 121 responses were received (18%). There was representation across all subspecialties with a mix of community and academic surgeons. The most commonly prescribed opioid was Codeine/Acetaminophen, 48.2% (n?=?53), in the adult population, and Morphine, 47.1% (n?=?41), in the pediatric population. The median total oral morphine equivalents prescribed across all adult surgeries was 123.75?mg (24.75 doses). The surgery with the highest oral morphine equivalents prescribed was tonsillectomy/adenoidectomy for both adult and pediatric patients, with a median of 150?mg (30 doses) for adults and 4.5?mg/kg (23 doses) for pediatrics. Gender, training years, year in residency, or reported level of conservatism did not predict the dose prescribed to either adult or pediatric patients. Due to the relatively low response rate, the generalizability of these results is unclear. Our study demonstrates a wide variability in opioid prescriptions across procedures and within each individual procedure. This variability reflects the lack of guidelines available for post-operative opioid prescribing and suggests that some Otolaryngologists may be prescribing higher doses of opioids than required. Opportunities for improving patient safety and resource stewardship regarding optimal prescribing practices should be explored.
机译:处方阿片类药物滥用已成为世界范围内的主要问题,尤其是在北美。加拿大是世界上人均阿片类药物处方数量第二高的国家,仅次于美国,并且近年来这一数字还在继续上升。外科医生在此讨论中起着至关重要的作用,因为他们负责处理患者的术后疼痛。这项研究的目的是评估加拿大耳鼻喉科医生-头颈外科医生的阿片类药物处方实践,并确定可能影响这些实践的因素。在线调查已分发给加拿大耳鼻咽喉头颈外科学会会员。问卷调查了受访者针对普通儿科和成人择期手术的人口统计学和类阿片处方操作。该调查已发送给670位外科医生和受训者,共收到121份答复(占18%)。社区和学术外科医生在所有子专业中都有代表。最常见的阿片类药物在成年人群中为可待因/对乙酰氨基酚,占48.2%(n?=?53),吗啡在儿科人群中,占47.1%(n?=?41)。在所有成人手术中,口服吗啡总当量的中位数为123.75?mg(24.75剂)。对于成人和小儿患者,口服吗啡当量最高的手术是扁桃体切除/腺样体切除术,成人中位数为150微克(30剂),小儿中位数为4.5微克/千克(23剂)。性别,培训年限,居住年限或报告的保守程度均未预测成人或儿童患者的处方剂量。由于响应率相对较低,这些结果的一般性尚不清楚。我们的研究表明,在整个过程中以及在每个单独的过程中,阿片类药物处方的差异很大。这种差异反映了缺乏可用于术后阿片类药物处方的指南,并表明一些耳鼻喉科医生可能开出了比所需剂量更高的阿片类药物剂量。应该探索在最佳处方实践方面改善患者安全性和资源管理的机会。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号